We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 669

Sham Hatch-Waxman infringement suits and FDA citizen petitions; a potential for new liability for innovators?

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • August 12 2014

Under what is commonly known as "Noerr-Pennington immunity," persons exercising their First Amendment right to petition the government for redress

The curious case of LabMD new developments in the “other” FTC data-security case

  • Mayer Brown LLP
  • -
  • USA
  • -
  • August 11 2014

By now, businesses with an interest in data security are aware of FTC v. Wyndham Worldwide Corp., in which a US District Court of New Jersey held

Federal Circuit finds that FDA citizen petition could give rise to antitrust liability

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • August 7 2014

In Tyco Healthcare Group LP v. Mutual Pharmaceutical Co., Inc., the Federal Circuit remanded-in-part for the district court to determine whether

State AGs in the news

  • Dickstein Shapiro LLP
  • -
  • USA
  • -
  • August 7 2014

The General Counsel of the National Labor Relations Board (NLRB) authorized 43 complaints of unfair labor practices brought by McDonald’s franchise

FTC v. Cephalon, the fray begins

  • Paul Hastings LLP
  • -
  • USA
  • -
  • August 7 2014

Last year in a landmark decision, the Supreme Court ruled that pharmaceutical "reverse payment" settlements in Hatch-Waxman Act "Paragraph 4" patent

Religious institutions: August 2014

  • Holland & Knight LLP
  • -
  • USA
  • -
  • August 6 2014

The IRS allegedly has a procedure in place for "signature authority" to initiate a church tax investigation or examination, subject to an independent

FTC proscription for antitrust enforcement in health care

  • Spencer Fane Britt & Browne LLP
  • -
  • USA
  • -
  • August 6 2014

On June 19, 2014, Deborah Feinstein, Director of the Federal Trade Commission's Bureau of Competition, addressed the Fifth National Accountable Care

Contractual duty to deal does not equal antitrust duty to deal

  • McDermott Will & Emery
  • -
  • USA
  • -
  • July 30 2014

Addressing for the first time whether a patent holder under a contractual duty to deal is also subject to an antitrust duty to deal, the U. S. Court

State AGs in the news

  • Dickstein Shapiro LLP
  • -
  • USA
  • -
  • July 24 2014

CWAG held its annual meeting this week in Park City, Utah, which was attended by several members of Dickstein Shapiro's State Attorneys General

PhRMA v FTC: FTC HSR rulemaking in the pharmaceutical industry upheld

  • Chadbourne & Parke LLP
  • -
  • USA
  • -
  • July 22 2014

The United States District Court for the District of Columbia recently upheld the Federal Trade Commission's rulemaking regarding the